Science Explorer Back to mapMap
Discussion
Company · Berkeley · United States

Aduro BioTech (United States)

Research works
52
▼ 84% vs 2018-21
Citations
3.8k
72.4 per fractional work
Top-10% rate
31.6%
all institutions 10.0%
Open access
54%
world 40%
International
22%
world 18%

Not ranked overall: Aduro BioTech (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Aduro BioTech (United States) work in?

In all years, 57% of research at Aduro BioTech (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Immunology and Microbiology (32%), Biochemistry, Genetics and Molecular Biology (23%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 30 fractional works · 56.6% of its workImmunology and Microbiology: 17 fractional works · 32.0% of its workImmunology: 17 fractional works · 32.0% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 23.1% of its workMolecular Biology: 5 fractional works · 8.6% of its workBiotechnology: 4 fractional works · 8.4% of its workGenetics: 2 fractional works · 3.6% of its workEndocrinology: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.5% of its workCancer Research: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.5% of its workNeurology: 0 fractional works · 0.8% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 18 fractional works · 34.4% of its workMedicine: 18 fractional works · 34.3% of its workOncology: 7 fractional works · 13.8% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.9% of its workInfectious Diseases: 2 fractional works · 3.3% of its workEpidemiology: 1 fractional works · 1.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.7% of its workHematology: 1 fractional works · 1.5% of its workNeurology: 1 fractional works · 1.5% of its workSurgery: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workNephrology: 0 fractional works · 0.8% of its workOphthalmology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.2% of its workEmergency Medicine: 0 fractional works · 0.2% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 8.6% of its workEngineering: 4 fractional works · 7.1% of its workBiomedical Engineering: 2 fractional works · 3.4% of its workElectrical and Electronic Engineering: 1 fractional works · 2.2% of its workMechanical Engineering: 0 fractional works · 0.8% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 0.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKAduro BioTech(United States)52fractional works, all years
Life Sciences57%Physical Sciences9%Health Sciences34%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Immunology and Microbiology1732.0%
    2. Biochemistry, Genetics and Molecular Biology1223.1%
    3. Neuroscience11.5%
    1. Medicine1834.3%
    2. Health Professions00.1%
    1. Engineering47.1%
    2. Materials Science00.6%
    3. Environmental Science00.6%
    4. Computer Science00.3%
    1. Psychology00.3%
    2. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Aduro BioTech (United States)?

Ranked on the quality score, Sarah M. McWhirter, Thomas Walter Dubensky and Kelsey E. Sivick lead among researchers whose main affiliation is Aduro BioTech (United States).

  1. 1 Sarah M. McWhirter United States · #41,791 worldwide 11k citations · 134 works
  2. 2 Thomas Walter Dubensky United States · #61,186 worldwide 12k citations · 321 works
  3. 3 Kelsey E. Sivick United States · #126,552 worldwide 4.4k citations · 84 works
  4. 4 Peter E. Lauer United States · #146,695 worldwide 13k citations · 125 works
  5. 5 Dirk G. Brockstedt United States · #149,974 worldwide 7.9k citations · 196 works
  6. 6 Chudi O. Ndubaku United States · #241,342 worldwide 3.2k citations · 56 works
  7. 7 Meredith L.L. Leong United States · #284,512 worldwide 3k citations · 71 works
  8. 8 David B. Kanne United States · #294,393 worldwide 4.8k citations · 81 works
  9. 9 Andrea van Elsas United States · #298,170 worldwide 5.9k citations · 78 works
  10. 10 George E. Katibah United States · #334,604 worldwide 7.4k citations · 27 works
All ranked researchers at Aduro BioTech (United States)

What are the most cited papers from Aduro BioTech (United States)?

The most cited paper from Aduro BioTech (United States) is "Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity" (Leticia P. Corrales, Laura Hix Glickman, Sarah M. McWhirter et al., 2015), with 1,558 citations. Next come "TOX is a critical regulator of tumour-specific T cell differentiation" (1,150) and "Chromatin states define tumour-specific T cell dysfunction and reprogramming" (955).

Most cited papers
#PaperReleasedCitations
1 Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity Leticia P. Corrales, Laura Hix Glickman, Sarah M. McWhirter et al. · Cell Reports Open access May 2015 1,558
2 TOX is a critical regulator of tumour-specific T cell differentiation Andrew Scott et al. · Nature Open access 17 Jun 2019 1,150
3 Chromatin states define tumour-specific T cell dysfunction and reprogramming Mary Philip, Lauren Fairchild, Liping Laura Sun et al. · Nature Open access May 2017 955
4 T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma Jennifer N. Brudno et al. · Journal of Clinical Oncology Open access 29 May 2018 800
5 Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis Andrea Schietinger, Mary Philip, Varintra E. Krisnawan et al. · Immunity Open access Aug 2016 751
All 60 most cited papers, with filters and sorting

Which keywords describe research at Aduro BioTech (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Innate Immunity, Immunotherapy, Cancer Immunotherapy, Antigen Presentation, Pattern Recognition Receptors, Gene Therapy, Immunity and Dendritic Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Innate Immunity10▲ 53×6 topics
  2. Immunotherapy8▲ 24×10 topics
  3. Cancer Immunotherapy8▲ 105×3 topics
  4. Antigen Presentation6▲ 109×2 topics
  5. Pattern Recognition Receptors5▲ 71×2 topics
  6. Gene Therapy5▲ 38×5 topics
  7. Immunity5▲ 30×2 topics
  8. Dendritic Cells5▲ 85×2 topics
  9. Tumor Antigen5▲ 118×1 topic
  10. Tumor Microenvironment5▲ 27×6 topics
  11. Vaccine Adjuvants5▲ 118×1 topic
  12. Tumor Regression5▲ 103×2 topics
  13. Tumor Targeting4▲ 61×3 topics
  14. Interferon Signaling4▲ 234×1 topic
  15. Viral Infection4▲ 104×1 topic
  16. Inflammation4▲ 3.1×15 topics
  17. Immune Checkpoint Blockade3▲ 117×1 topic
  18. PD-1 and PD-L13▲ 117×1 topic
  19. Epidemiology3▲ 1.57×13 topics
  20. Arginine Deprivation3▲ 142×1 topic
  21. Bacterial Therapy3▲ 142×1 topic
  22. Autoimmunity2▲ 21×2 topics
  23. NK Cell Recognition2▲ 42×1 topic
  24. Natural Killer Cells2▲ 42×1 topic
  25. Pathogenesis2▲ 6.6×5 topics
  26. Chemotherapy2▲ 4.8×6 topics
  27. TGF-ß2▲ 20×2 topics
  28. CD4+CD25+2▲ 45×1 topic
  29. Foxp32▲ 45×1 topic
  30. Glycosylation2▲ 15×3 topics
  31. Monoclonal Antibodies2▲ 21×3 topics
  32. Toll-like Receptors2▲ 18×2 topics
  33. CAR T Cells2▲ 64×1 topic
  34. Chimeric Antigen Receptor2▲ 64×1 topic
  35. Cytokine-Mediated Link2▲ 42×1 topic
  36. Innate Antiviral Responses2▲ 42×1 topic
  37. Therapeutic Antibodies2▲ 23×2 topics
  38. Antibody Engineering1▲ 27×1 topic
  39. Fc Receptors1▲ 27×1 topic
  40. Immune Regulation1▲ 20×2 topics

Which research topics does Aduro BioTech (United States) publish most on?

By volume in 2022-now: Viral Infections and Vectors, interferon and immune responses, Monoclonal and Polyclonal Antibodies Research and Immune Cell Function and Interaction.

  1. 1 Viral Infections and Vectors Infectious Diseases 0 works
  2. 2 interferon and immune responses Immunology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Immune Cell Function and Interaction Immunology 0 works
  5. 5 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  6. 6 Nanofabrication and Lithography Techniques Biomedical Engineering 0 works
  7. 7 Nanotechnology research and applications Biomedical Engineering 0 works
  8. 8 Advanced Materials and Mechanics Mechanical Engineering 0 works
  9. 9 Protein purification and stability Molecular Biology 0 works
  10. 10 Glycosylation and Glycoproteins Research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.8%not open46.2%

World: 40% of research is openly available.

with international co-authors22.0%domestic only78.0%

World: 18% is written across borders.

How has Aduro BioTech (United States)'s research output changed?

Output in 2022-2025 was 84% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Aduro BioTech (United States) as a percentage of every work published that year, 0.000019% in 2023.

still counting0.00010%0.00020%Aduro BioTech (United States)0.000018% in 202520102020

Fractional works of Aduro BioTech (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Berkeley

All research institutions in Berkeley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Aduro BioTech (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.